Speciality Medicines Limited (BOM:544738)

India · Delayed Price · Currency is INR

165.50

+3.00 (1.85%)

At close: Aug 17, 2026

33.47% (1Y)

Market Cap	1.45B
Revenue (ttm)	752.85M +86.1%
Net Income	130.33M +781.0%
EPS	20.11 +313.1%
Shares Out	8.79M
PE Ratio	8.23
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,000
Open	166.00
Previous Close	162.50
Day's Range	164.05 - 166.90
52-Week Range	121.10 - 381.20
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 28, 2026

About Speciality Medicines

Speciality Medicines Limited engages in the manufacturing, marketing and distribution of finished formulations of specialty pharmaceutical products in India and internationally. The company offers tablets, capsules, cream, syrups, eye drops, gel, infusion, inhalation, inhaler, injection, nasal spray, ointment, ophthalmic, oral solution, oral suspension, sachet, and suspension for oncology, immunology, neurology, and rare diseases therapeutic areas. It also provides patient, hospitals, institutions and NGO supplies, validated controlled supply m... [Read more]

Industry Pharmaceutical Preparations

Founded 2021

Country India

Stock Exchange Bombay Stock Exchange

Ticker Symbol 544738

Full Company Profile

Financial Performance

In fiscal year 2026, Speciality Medicines's revenue was 752.85 million, an increase of 29.20% compared to the previous year's 582.71 million. Earnings were 130.33 million, an increase of 81.11%.

Financial Statements